Compare PEO & OFIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PEO | OFIX |
|---|---|---|
| Founded | 1929 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 570.8M | 500.2M |
| IPO Year | N/A | 1998 |
| Metric | PEO | OFIX |
|---|---|---|
| Price | $26.83 | $11.69 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $17.25 |
| AVG Volume (30 Days) | 73.5K | ★ 286.4K |
| Earning Date | 01-01-0001 | 05-05-2026 |
| Dividend Yield | ★ 5.93% | N/A |
| EPS Growth | N/A | ★ 29.39 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $822,312,000.00 |
| Revenue This Year | N/A | $6.32 |
| Revenue Next Year | N/A | $6.01 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 2.85 |
| 52 Week Low | $18.35 | $10.25 |
| 52 Week High | $27.12 | $17.00 |
| Indicator | PEO | OFIX |
|---|---|---|
| Relative Strength Index (RSI) | 62.67 | 30.85 |
| Support Level | $21.14 | $10.55 |
| Resistance Level | $27.12 | $16.38 |
| Average True Range (ATR) | 0.58 | 0.45 |
| MACD | -0.04 | -0.06 |
| Stochastic Oscillator | 81.17 | 7.82 |
Adams Natural Resources Fund Inc is a non-diversified U.S. equity fund that invests in liquid energy and other natural resources stocks. The Fund's investment objectives are preservation of capital, reasonable income, and opportunity for capital gain. A majority of its assets are invested in petroleum or natural resources industries or industries connected to them. It has broad flexibility to invest in stocks of varying capitalizations and predominantly invests in stocks found in the S&P 500 Energy and S&P 500 Materials sectors.
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.